Bromperidol maintenance in schizophrenia.

J. P. McEvoy, W. H. Wilson, T. A. Ban, J. O. Brannen, S. Berney

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.

Original languageEnglish (US)
Pages (from-to)95-96
Number of pages2
JournalPharmacopsychiatria
Volume15
Issue number3
StatePublished - May 1 1982
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

McEvoy, J. P., Wilson, W. H., Ban, T. A., Brannen, J. O., & Berney, S. (1982). Bromperidol maintenance in schizophrenia. Pharmacopsychiatria, 15(3), 95-96.